{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:46:20Z","timestamp":1794581180255,"version":"4.9.1"},"reference-count":43,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Actial Farmaceutica Srl.","award":["none"],"award-info":[{"award-number":["none"]}]},{"name":"Ferring SAU","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Gastrointestinal symptomatology is frequent among patients with fibromyalgia, which increases disease burden and lacks specific treatment, either pharmacological or non-pharmacological. We aimed to evaluate the efficacy and tolerability of a multi-strain probiotic, VSL#3\u00ae, for the treatment of fibromyalgia-associated gastrointestinal manifestations. This randomized, placebo-controlled trial included 12 weeks of probiotic or placebo treatment followed by 12 weeks of follow up. The primary outcome variable was the mean change from the baseline to the endpoint in the composite severity score of the three main gastrointestinal symptoms reported by patients with fibromyalgia (abdominal pain, abdominal bloating and meteorism). Secondary outcome variables were the severity of additional gastrointestinal symptoms, fibromyalgia severity, depression, sleep disturbance, health-related quality of life and patients\u2019 overall impression of improvement. No differences were found between VSL#3\u00ae (n = 54) and the placebo (n = 56) in the primary outcome (estimated treatment difference: 1.1; 95% confidence interval [CI]: \u22122.1, 4.2; p = 0.501), or in any of the secondary outcomes. However, responders to VSL#3 were more likely to maintain any improvement during the follow-up period compared to responders in the placebo arm. Overall, VSL#3 tolerability was good. Our data could not demonstrate any beneficial effects of VSL#3\u00ae either on the composite score of severity of abdominal pain, bloating and meteorism or in any of the secondary outcome variables. More research is needed to elucidate specific factors that may predict a favourable response to treatment in patients with fibromyalgia.<\/jats:p>","DOI":"10.3390\/ph14101063","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T03:01:13Z","timestamp":1634698873000},"page":"1063","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Probiotic VSL#3\u00ae Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial"],"prefix":"10.3390","volume":"14","author":[{"given":"Elena P.","family":"Calandre","sequence":"first","affiliation":[{"name":"Instituto de Neurociencias, Universidad de Granada, 18100 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Hidalgo-Tallon","sequence":"additional","affiliation":[{"name":"Instituto de Neurociencias, Universidad de Granada, 18100 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Molina-Barea","sequence":"additional","affiliation":[{"name":"Servicio de Cirug\u00eda, Complejo Hospitalario de Jaen, 23007 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rico-Villademoros","sequence":"additional","affiliation":[{"name":"Instituto de Neurociencias, Universidad de Granada, 18100 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-5666","authenticated-orcid":false,"given":"Cristina","family":"Molina-Hidalgo","sequence":"additional","affiliation":[{"name":"Departamento de Psicolog\u00eda M\u00e9dica, Universidad de Granada, 18011 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-3660","authenticated-orcid":false,"given":"Juan M.","family":"Garcia-Leiva","sequence":"additional","affiliation":[{"name":"Instituto de Neurociencias, Universidad de Granada, 18100 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Carrillo-Izquierdo","sequence":"additional","affiliation":[{"name":"Departamento de Enfermer\u00eda, Universidad Cat\u00f3lica de Murcia, 30107 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-1432","authenticated-orcid":false,"given":"Mahmoud","family":"Slim","sequence":"additional","affiliation":[{"name":"Division of Neurology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","article-title":"Fibromyalgia and related conditions","volume":"90","author":"Clauw","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/10582450903284752","article-title":"Central Sensitivity Syndromes: An Overview","volume":"17","author":"Yunus","year":"2009","journal-title":"J. Musculoskelet. Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00296-014-3109-9","article-title":"An insight into the gastrointestinal component of fibromyalgia: Clinical manifestations and potential underlying mechanisms","volume":"35","author":"Slim","year":"2015","journal-title":"Rheumatol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1756284820977402","DOI":"10.1177\/1756284820977402","article-title":"A systematic review of the association between fibromyalgia and functional gastrointestinal disorders","volume":"13","author":"Erdrich","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1300\/J094v09n03_10","article-title":"Small Intestinal Bacterial Overgrowth: A Possible Association with Fibromyalgia","volume":"9","author":"Pimentel","year":"2001","journal-title":"J. Musculoskelet. Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2003.011502","article-title":"A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing","volume":"63","author":"Pimentel","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/rheumatology\/ken140","article-title":"Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome","volume":"47","author":"Goebel","year":"2008","journal-title":"Rheumatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40168-017-0261-y","article-title":"Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"5","author":"Williams","year":"2017","journal-title":"Microbiome"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","article-title":"Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia","volume":"46","author":"Abecia","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1097\/j.pain.0000000000001640","article-title":"Altered microbiome composition in individuals with fibromyalgia","volume":"160","author":"Minerbi","year":"2019","journal-title":"Pain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3899\/jrheum.090024","article-title":"Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: A comparative study","volume":"36","author":"Pamuk","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s00296-011-2010-z","article-title":"Dietary aspects in fibromyalgia patients: Results of a survey on food awareness, allergies, and nutritional supplementation","volume":"32","author":"Arranz","year":"2012","journal-title":"Rheumatol. Int."},{"key":"ref_13","first-page":"480","article-title":"Patterns of food avoidance and eating behavior in women with fibromyalgia","volume":"64","year":"2017","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_14","first-page":"72","article-title":"Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: A patients\u2019 survey","volume":"38","author":"Calandre","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_15","first-page":"25","article-title":"Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis","volume":"14","author":"Bull","year":"2015","journal-title":"Integr. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13099-017-0224-7","article-title":"Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood","volume":"9","author":"Yusof","year":"2017","journal-title":"Gut Pathog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: The efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e13427","DOI":"10.1111\/nmo.13427","article-title":"Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome","volume":"30","author":"Connell","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_19","first-page":"963","article-title":"The safety profile of probiotic VSL#3(R). A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials","volume":"24","author":"Panetta","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_20","first-page":"619","article-title":"Placebo responders in randomized controlled drug trials of fibromyalgia syndrome: Systematic review and meta-analysis","volume":"25","author":"Hauser","year":"2011","journal-title":"Schmerz"},{"key":"ref_21","first-page":"78","article-title":"Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: Systematic review and meta-analysis","volume":"30","author":"Hauser","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10067-017-3595-8","article-title":"The placebo effect and its determinants in fibromyalgia: Meta-analysis of randomised controlled trials","volume":"36","author":"Chen","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3748\/wjg.v13.i25.3425","article-title":"Placebo responses in patients with gastrointestinal disorders","volume":"13","author":"Musial","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1468-1331.2011.03528.x","article-title":"Nocebo in fibromyalgia: Meta-analysis of placebo-controlled clinical trials and implications for practice","volume":"19","author":"Mitsikostas","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dale, H.F., Rasmussen, S.H., Asiller, O.O., and Lied, G.A. (2019). Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients, 11.","DOI":"10.3390\/nu11092048"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijsu.2020.01.142","article-title":"The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials","volume":"75","author":"Niu","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fphar.2020.00332","article-title":"Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/j.gastro.2020.05.060","article-title":"AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders","volume":"159","author":"Preidis","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"De Simone, C. (2020). Comment on: \u201cSearch and Selection of Probiotics that Improve Mucositis Symptoms in Oncologic Patients: A Systematic Review. Nutrients, 12.","DOI":"10.3390\/nu12020399"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10965","DOI":"10.1038\/s41598-018-29388-5","article-title":"A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in Fibromyalgia","volume":"8","author":"Roman","year":"2018","journal-title":"Sci Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ije\/dyz032","article-title":"Accounting for missing data in statistical analyses: Multiple imputation is not always the answer","volume":"48","author":"Hughes","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105150","DOI":"10.1016\/j.phrs.2020.105150","article-title":"Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1\/M2 phenotype macrophage in db\/db mice","volume":"161","author":"Wang","year":"2020","journal-title":"Pharmacol Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"681014","DOI":"10.3389\/fmicb.2021.681014","article-title":"Effect of a Multispecies Probiotic Mixture on the Growth and Incidence of Diarrhea, Immune Function, and Fecal Microbiota of Pre-weaning Dairy Calves","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5597401","DOI":"10.1155\/2021\/5597401","article-title":"Probiotic Supplement Preparation Relieves Test Anxiety by Regulating Intestinal Microbiota in College Students","volume":"2021","author":"Qin","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/gerona\/glaa090","article-title":"Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","volume":"76","author":"Kim","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/1751-7915.13476","article-title":"Development of omics-based protocols for the microbiological characterization of multi-strain formulations marketed as probiotics: The case of VSL#3","volume":"12","author":"Mora","year":"2019","journal-title":"Microb. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1477-7525-11-132","article-title":"Validation of a Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR)","volume":"11","author":"Salgueiro","year":"2013","journal-title":"Health Qual. Life Outcomes."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4067\/S0717-92272012000100002","article-title":"Validaci\u00f3n y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagn\u00f3stico de depresi\u00f3n en pacientes usuarios de atenci\u00f3n primaria en Chile","volume":"50","author":"Baader","year":"2012","journal-title":"Rev. Chil. De Neuro-Psiquiatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.sleep.2011.06.019","article-title":"The Spanish version of the Insomnia Severity Index: A confirmatory factor analysis","volume":"13","author":"Calhoun","year":"2012","journal-title":"Sleep Med."},{"key":"ref_43","first-page":"771","article-title":"The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results","volume":"104","author":"Alonso","year":"1995","journal-title":"Med. Clin."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/10\/1063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:18:15Z","timestamp":1760167095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/10\/1063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ph14101063"],"URL":"https:\/\/doi.org\/10.3390\/ph14101063","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}